# A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors

> **NCT00329004** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 89 (actual)

## Conditions studied

- Cancer
- Tumor

## Interventions

- **DRUG:** BMS-690514

## Key facts

- **NCT ID:** NCT00329004
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2011-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00329004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00329004, "A Phase I Study of BMS-690514 in Patients With Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00329004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*